abrdn plc
Institutional investorEdinburgh
Find your way into abrdn plc
Investment thesis
abrdn is an asset management and investment firm offering a range of strategies for institutional investors and intermediaries, along with investment trusts for individual investors.
Source: firm website, verified Aug 3, 2026.
What they invest in
from 12 of 12 portfolio companiesBiotech ×10Healthtech ×5Medical Devices ×5Digital Health ×3Deep Tech ×1Direct to Consumer ×1Enterprise Software ×1Fintech ×1
HQs:United States×7Canada×1United Kingdom×1Luxembourg×1
Investments · 12 tracked
founders shown can be your intro pathBy year:2026 · 32025 · 22024 · 22016 · 18 dated
Veradermics is developing VDPHL01, an extended-release oral minoxidil tablet intended as a non-hormonal prescription treatment for pattern hair loss in women and men.
BiotechHealthtechWest Hartford, US
Reid Waldman(Chief Executive Officer and Board Member)inTim Durso(Chief Technical Officer)inDominic Carrano(Chief Financial Officer and Treasurer)inMark Neumann(Chief Commercial and Strategy Officer)John W. Childs(Director)Jane Grant-Kels(Director)
Co-investorsLongitude CapitalConnecticut InnovationsOUP (Osage University Partners)SR One Capital ManagementInvusLifeSci Venture Partners
CuraSen Therapeutics is a privately funded biopharmaceutical company developing treatments that selectively activate adrenergic receptors in the brain to restore noradrenergic signaling.
BiotechHealthtech
Anthony Fordin
Co-investorsAlta PartnersLongitude CapitalIntermediate Capital GroupJohnson & Johnson Innovation – JJDCNew Leaf Venture PartnersPappas Capital+2 more
Engrail Therapeutics is a clinical-stage pharmaceutical company developing precision-targeted therapeutics for neupropsychiatric and neurodevelopmental disorders.
BiotechDigital HealthMedical DevicesSan Diego, US
Stephen(Co-founder, EVP Research & Development and Chief Development Officer)Paul Cayer(Chief Financial Officer)inVikram(President and Chief Executive Officer)Kimberly(Chief Scientific Officer)Quentin(Chief Technical Officer)
Co-investorsForesite CapitalLongwood FundNorwest Venture PartnersRiverVest Venture PartnersYsios CapitalEight Roads Ventures+4 more
Abcuro develops therapies that target highly cytotoxic T cells for autoimmune diseases, including its lead candidate ulviprubart for inclusion body myositis.
BiotechHealthtechNewton, US
Steven A. Greenberg(Chief Scientific Advisor & Co-Founder)Steven A. Greenberg, MD(Chief Scientific Advisor & Co-Founder)John Alexander Martin(Executive Officer, Director)Stefano Gulla(Executive Officer)Evan Thompson(Executive Officer)David de Graaf(Executive Officer, Director)
Co-investorsBain Capital Life SciencesNew Enterprise Associates (NEA)RA CapitalSamsara BioCapitalSanofi VenturesMass General Brigham Ventures+9 more
AgelessRx offers prescription weight management medications delivered through a telehealth platform, including GLP-1 medications (semaglutide, tirzepatide), FDA-approved weight loss drugs (Wegovy, Zepbound), and supportive treatments like metformin and vitamin injections for adults seeking medically-supervised weight loss.
BiotechDigital HealthDirect to ConsumerHealthtechLongevityAnn Arbor, US
Anar Isman(Co-Founder & Chief Executive Officer)inRobert Michael Pejovich(Director of Finance of the Issuer)
Co-investors1/1 CapitalAngelini VenturesFidelity InvestmentsJanus Henderson InvestorsSanofi Ventures
Alpha-9 Oncology develops radiopharmaceuticals for cancer treatment, with a portfolio of molecules in clinical and preclinical development.
BiotechDigital HealthMedical DevicesVancouver, CA
François Bénard(MD)Kuo-Shyan Lin(PhD)David Perrin(PhD)
Co-investorsAndreessen HorowitzAscenta CapitalDelos CapitalGeneral CatalystLightspeed Venture PartnersLongitude Capital+9 more
.png)
Atalanta is developing treatment options for intractable central nervous system diseases using RNA interference technology.
BiotechDeep TechHealthtechMedical Devices
Co-investorsF-Prime CapitalNovartis Venture FundRiverVest Venture PartnersSanofi VenturesEQT Life Sciences
Matter is a real estate investment firm focused on the living sector, investing across sub-sectors such as single- and multi-family, senior living, and affordable housing.
Impact & Social GoodPropTech
David Christie(CEO)in
Co-investorsBlack Lion VenturesGCM GrosvenorUBS
Qlaris Bio is a clinical-stage biotechnology company developing therapies for ophthalmology conditions.
BiotechMedical DevicesDedham, US
Thurein Htoo(Executive Officer, Director)inFred Guerard(President & Chief Executive Officer)inBarbara Wirostko(Executive Officer)
BoardWende Hutton(Director)inRonald M. Hunt(Director)Andrew Danielson(Director)
Co-investorsCanaan PartnersCorrelation VenturesMayo Clinic VenturesNew Leaf Venture Partners
Third Arc Bio develops breakthrough treatments in oncology and immunology through advanced biologics engineering.
BiotechMedical DevicesLower Gwynedd, US
Joseph Erhardt(Executive Officer)inPeter Lebowitz(Executive Officer, Director)
BoardArjun Goyal(Director)inOtello Stampacchia(Director)inFrancesco Draetta(Director)in
Co-investorsAndreessen HorowitzVida VenturesBiotechnology Value FundForesite CapitalHillhouse InvestmentOmega Funds+1 more
Titanbay provides infrastructure technology connecting asset managers and distributors to manage private market funds, handling fund structuring, onboarding, capital flows, reporting, and compliance at scale.
Enterprise SoftwareFintechSaaSLuxembourg, LU
Co-investorsMotive Partners
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Exits · 1
1 IPOsVeradermicsNYSE: MANE
Portfolio news
latest coverage across their companies
Abcuro · clinicaltrialsarena.com · Aug 19, 2026
Titanbay · wealthbriefing.com · Aug 13, 2026
AgelessRx · longevity.technology · Aug 11, 2026
Third Arc Bio · allsci.com · Feb 4, 2026
Matter Real Estate · perenews.com · Oct 6, 2025
Glycomine · finsmes.com · Apr 16, 2025
Fund performance · per public LP disclosures · 5
as of Jun 2025| Fund | Vintage | Committed | Net IRR | TVPI | DPI |
|---|---|---|---|---|---|
| SL Capital SOF III, L.P.LPs: San Bernardino County Employees Retirement Association | 2017 | — | 18.2% | — | 1.97x |
| SL Capital SOF II, L.P.LPs: San Bernardino County Employees Retirement Association | 2015 | — | 13.9% | — | 1.58x |
| SL Capital SOF I, L.P.LPs: San Bernardino County Employees Retirement Association, Merseyside Pension Fund | 2014 | — | 9.3% | — | 1.36x |
| SL Capital Infrastructure ILPs: West Yorkshire Pension Fund, Merseyside Pension Fund | — | — | — | 1.75x | 0.37x |
| SL Capital Infrastructure IILPs: West Yorkshire Pension Fund, Merseyside Pension Fund | — | — | — | 1.16x | 0.34x |
Source: public limited-partner disclosures (CalPERS, CalSTRS). Net IRR / TVPI / DPI as reported by the limited partner; a fund's early-year IRR is an interim estimate (J-curve).
Frequently asked questions
- How many investments has abrdn plc made?
- abrdn plc has 12 tracked investments, 1 of which have exited, including 6 dated in the last 24 months.
- What sectors does abrdn plc focus on?
- abrdn plc focuses on Crypto & Web3.
- Where is abrdn plc located?
- abrdn plc is headquartered in Edinburgh, GB.
Similar investors
AirTree Ventures runs Pathfinders, a free four-week in-person program in Sydney for young builders (high-school graduates up to age 23) to work on a real product, access the AirTree team and founders, and build a peer network.
Andreessen Horowitz (a16z) is a venture capital firm founded in 2009 by Marc Andreessen and Ben Horowitz, known for pioneering the platform model with a large team of operators supporting founders across stages.
Atomico is an international venture capital firm that invests in growth-stage technology companies across multiple geographies. The firm focuses on scaling disruptive technology businesses globally.
August Capital is a venture capital firm that invests in a small number of companies, providing hands-on support to entrepreneurs building their businesses.
.jpeg){kind=logo}
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.